Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 13, 2013 - Issue 8
Submit an article Journal homepage
521
Views
13
CrossRef citations to date
0
Altmetric
Reviews

Immune thrombocytopenia – what are the new treatment options?

Simon HallamQueen Mary University of London, Bart's & The London School of Medicine and Dentistry, Department of Haematology, Whitechapel, London El 2ES, UK
,
Drew ProvanQueen Mary University of London, Bart's & The London School of Medicine and Dentistry, Department of Haematology, Whitechapel, London El 2ES, UK
&
Adrian C NewlandThe Royal London Hospital, Department of Haematology, Pathology & Pharmacy Building, 80 Newark Street, London E1 2ES, UK+0203 246 0338; +0203 246 0351; [email protected]
Pages 1173-1185 | Published online: 17 May 2013

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Frederick Chen, Vickie McDonald & Adrian Newland. (2021) Experts’ review: the emerging roles of romiplostim in immune thrombocytopenia (ITP). Expert Opinion on Biological Therapy 21:11, pages 1383-1393.
Read now
John D. Grainger & Sharon Thind. (2017) A practical guide to the use of eltrombopag in children with chronic immune thrombocytopenia. Pediatric Hematology and Oncology 34:2, pages 73-89.
Read now

Articles from other publishers (11)

Zayar Oo, Kapilkumar Manvar & Jen Chin Wang. (2022) Eltrombopag-Induced Thrombocytosis and Thrombosis in Patients With Antiphospholipid Syndrome and Immune Thrombocytopenic Purpura. Journal of Investigative Medicine High Impact Case Reports 10, pages 232470962110605.
Crossref
Qiuhong Wang, Haocai Chang, Qi Shen, Yonghua Li & Da Xing. (2021) Photobiomodulation therapy for thrombocytopenia by upregulating thrombopoietin expression via the ROS‐dependent Src/ERK/STAT3 signaling pathway. Journal of Thrombosis and Haemostasis 19:8, pages 2029-2043.
Crossref
Zelie Guitton, Louis Terriou, Jean-Christophe Lega, Raphaele Nove-Josserand, Miguel Hie, Zahir Amoura, James B Bussel, Mohamed Hamidou, Eric Rosenthal, Bertrand Lioger, Dominique Chauveau, Axel Chaminade, Nadine Magy-Bertrand, Marc Michel, Sylvain Audia, Bertrand Godeau & Matthieu Mahevas. (2018) Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists. Rheumatology 57:8, pages 1432-1438.
Crossref
Francesco Rodeghiero & Giuseppe Carli. (2017) Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists. Annals of Hematology 96:9, pages 1421-1434.
Crossref
Qi ZhangTingting DongPeiyu LiMei X. Wu. (2016) Noninvasive low-level laser therapy for thrombocytopenia. Science Translational Medicine 8:349.
Crossref
Adrian Newland, Bertrand Godeau, Victor Priego, Jean-Francois Viallard, María F. López Fernández, Amelia Orejudos & Melissa Eisen. (2016) Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study. British Journal of Haematology 172:2, pages 262-273.
Crossref
Drew Provan & Adrian C Newland. 2015. Postgraduate Haematology. Postgraduate Haematology 773 782 .
Thomas Kühne. (2015) Treatment of Pediatric Primary Immune Thrombocytopenia With Thrombopoietin Receptor Agonists. Seminars in Hematology 52:1, pages 25-30.
Crossref
Danila Leontyev, Anton Neschadim & Donald R. Branch. (2014) Cytokine profiles in mouse models of experimental immune thrombocytopenia reveal a lack of inflammation and differences in response to intravenous immunoglobulin depending on the mouse strain. Transfusion 54:11, pages 2871-2879.
Crossref
Phillip Scheinberg, Cristiane Carvalho Singulane, Luis Sergio Guedes Barbosa & Morton Scheinberg. (2014) Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag. Clinical Rheumatology 33:9, pages 1347-1349.
Crossref
Abdulgabar Salama, Dirk Hartnack, Hans-Walter Lindemann, Hans-Joachim Lange, Mathias Rummel & Andreas Loew. (2014) The Effect of Erythropoiesis-Stimulating Agents in Patients with Therapy-Refractory Autoimmune Hemolytic Anemia. Transfusion Medicine and Hemotherapy 41:6, pages 462-468.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.